RankingsPricing
  1. JP-listed companies
  2. TAIKO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Revenue

TAIKO PHARMACEUTICAL CO., LTD.【JP:4574】

Market cap
¥14.6B
P/E ratio
25x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Dec 31, 20246,292+2.81%
Dec 31, 20236,120+21.43%
Dec 31, 20225,040-55.39%
Dec 31, 202111,299-35.74%
Dec 31, 202017,583+17.48%
Mar 31, 202014,966+43.65%
Mar 31, 201910,419+10.14%
Mar 31, 20189,459+14.04%
Mar 31, 20178,295-0.39%
Mar 31, 20168,327-7.26%
Mar 31, 20158,979-9.74%
Mar 31, 20149,947+33.63%
Mar 31, 20137,444+11.37%
Mar 31, 20126,684

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)